Evidence map›Paper›PMID 33127335›Full record

ReviewJournal of infection and public health2020

COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome.

Fahad Alsohime, Mohamad-Hani Temsah, Abdulrahman M Al-Nemri, Ali M Somily, Sarah Al-Subaie

Abstract readReview
In one paragraph

Review in Journal of infection and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Principles of Rational COVID-19 Therapy in Pediatrics.Journal of clinical medicine · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fahad AlsohimeCollege of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Pediatric, King Saud University Medical City, Riyadh, Saudi Arabia.
Mohamad-Hani TemsahCollege of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Pediatric, King Saud University Medical City, Riyadh, Saudi Arabia.
Abdulrahman M Al-NemriCollege of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Pediatric, King Saud University Medical City, Riyadh, Saudi Arabia.
Ali M SomilyCollege of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Pathology and Laboratory Medicine, King Saud University Medical City, Riyadh, Saudi Arabia.
Sarah Al-SubaieCollege of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Pediatric, King Saud University Medical City, Riyadh, Saudi Arabia. Electronic address: salsubaie@ksu.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel COVID-19 infections caused major morbidity and mortality globally in the adult age group. Likewise, SARS-COV-2 infections in children are highly risky in the selected patient population. We performed a focused literature search of published reports from December 1, 2019, till August 20, 2020. The aim was to explore the etiology, clinical presentations, and outcome of pediatric COVID-19 patients. Viral respiratory infections are associated with high societal costs for children. In addition, children with asymptomatic SARS-COV-2 infections can be a source of COVID-19 spread to parents and caregivers. The major reported risk factors for pediatric COVID-19 cases were close contact with a SARS-COV-2 positive family member, a history of travel, and/or living in endemic areas. Children with COVID-19 who required ICU care had various comorbidities, such as malignancy. As the pandemic evolved, multiple cases of multisystem inflammatory syndrome in children and adolescents temporarily related to covid-19 (MIS-C) were reported. A unique population is neonates born to COVID-19 affected mothers, as there is an urgent need to optimize their management and outcome during this rapidly evolving pandemic. The early identification of SARS-COV-2 infection in infants and children has important direct management effects in these children and public health implications because of the effects on disease transmission control measures.

Indexed as

SARS-CoV-2Systemic Inflammatory Response SyndromeChildChild Health ServicesCOVID-19FemaleHumansMalePrevalenceCOVID-19InfectionPediatricsSARS-CoV-2

Identifiers

PMID33127335
PMCPMC7574780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.